Skip to main content

Enloe Courtney C's Form 4 filing

Bio-Rad Laboratories, Inc. (BIO) · filed Sep 9, 2026

Accession no.
0002019843-26-000004
Filed
Sep 9, 2026, 6:45 PM ET
Trade date
Sep 4-6, 2026
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Enloe Courtney CCIK 0002019843Officer (EVP, General Counsel & Sec)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 5, 2026Bio-Rad A Common StockMOption exerciseAcquired+685$0.00$01,434.777Direct
Sep 5, 2026Bio-Rad A Common StockFTax withholdingDisposed−246$386.11−$94,983.061,188.777Direct
Sep 6, 2026Bio-Rad A Common StockMOption exerciseAcquired+768$0.00$01,956.777Direct
Sep 6, 2026Bio-Rad A Common StockFTax withholdingDisposed−305$386.11−$117,763.551,651.777Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 4, 2026Bio-Rad A Common StockAGrant or awardAcquired+2,876$0.00$02,876Direct
Sep 5, 2026Bio-Rad A Common StockMOption exerciseDisposed−685$0.00$02,055Direct
Sep 6, 2026Bio-Rad A Common StockMOption exerciseDisposed−768$0.00$01,536Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)